Advances with microRNAs in Parkinson’s disease research

References

• Robinson PA Protein stability and aggregation in Parkinson’s disease Biochem J 2008 413 1 1 13 18537793
   PubMed Web of Science ®Google Scholar
• Savitt JM Dawson VL Dawson TM Diagnosis and treatment of Parkinson disease: molecules to medicine J Clin Invest 2006 116 7 1744 1754 16823471
   PubMed Web of Science ®Google Scholar
• Parkinson J An Essay on the Shaking Palsy London Sherwood, Neely and Jones 1817
   Google Scholar
• D’Amelio M Ragonese P Sconzo G Aridon P Savettieri G Parkinson’s disease and cancer: insights for pathogenesis from epidemiology Ann N Y Acad Sci 2009 1155 324 334 19250224
   PubMed Web of Science ®Google Scholar
• Harraz MM Dawson TM Dawson VL MicroRNAs in Parkinson’s disease J Chem Neuroanat 2011 42 2 127 130 21295133
   PubMed Web of Science ®Google Scholar
• Hamza TH Zabetian CP Tenesa A Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson’s disease Nat Genet 2010 42 9 781 785 20711177
   PubMed Web of Science ®Google Scholar
• Dawson TM Dawson VL Molecular pathways of neurodegeneration in Parkinson’s disease Science 2003 302 5646 819 822 14593166
   PubMed Web of Science ®Google Scholar
• Gasser T Molecular pathogenesis of Parkinson disease: insights from genetic studies Expert Rev Mol Med 2009 11 e22 19631006
   PubMed Web of Science ®Google Scholar
• Simon-Sanchez J Schulte C Bras JM Genome-wide association study reveals genetic risk underlying Parkinson’s disease Nat Genet 2009 41 12 1308 1312 19915575
   PubMed Web of Science ®Google Scholar
• Lee RC Feinbaum RL Ambros V The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 Cell 1993 75 5 843 854 8252621
   PubMed Web of Science ®Google Scholar
• Bartel DP MicroRNAs: genomics, biogenesis, mechanism, and function Cell 2004 116 2 281 297 14744438
   PubMed Web of Science ®Google Scholar
• Bushati N Cohen SM microRNA functions Annu Rev Cell Dev Biol 2007 23 175 205 17506695
   PubMed Web of Science ®Google Scholar
• Lee Y Kim M Han J MicroRNA genes are transcribed by RNA polymerase II EMBO J 2004 23 20 4051 4060 15372072
   PubMed Web of Science ®Google Scholar
• Garzon R Marcucci G Croce CM Targeting microRNAs in cancer: rationale, strategies and challenges Nat Rev Drug Discov 2010 9 10 775 789 20885409
   PubMed Web of Science ®Google Scholar
• Borchert GM Lanier W Davidson BL RNA polymerase III transcribes human microRNAs Nat Struct Mol Biol 2006 13 12 1097 1101 17099701
   PubMed Web of Science ®Google Scholar
• Lee YS Nakahara K Pham JW Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways Cell 2004 117 1 69 81 15066283
   PubMed Web of Science ®Google Scholar
• Bartel DP MicroRNAs: target recognition and regulatory functions Cell 2009 136 2 215 233 19167326
   PubMed Web of Science ®Google Scholar
• Abe M Bonini NM MicroRNAs and neurodegeneration: role and impact Trends Cell Biol 2013 23 1 30 36 23026030
   PubMed Web of Science ®Google Scholar
• Kuss AW Chen W MicroRNAs in brain function and disease Curr Neurol Neurosci Rep 2008 8 3 190 197 18541114
   PubMed Web of Science ®Google Scholar
• Enciu AM Popescu BO Gheorghisan-Galateanu A MicroRNAs in brain development and degeneration Mol Biol Rep 2012 39 3 2243 2252 21643950
   PubMed Web of Science ®Google Scholar
• Kosik KS The neuronal microRNA system Nat Rev Neurosci 2006 7 12 911 920 17115073
   PubMed Web of Science ®Google Scholar
• Guo H Ingolia NT Weissman JS Bartel DP Mammalian microR-NAs predominantly act to decrease target mRNA levels Nature 2010 466 7308 835 840 20703300
   PubMed Web of Science ®Google Scholar
• Lewis BP Burge CB Bartel DP Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Cell 2005 120 1 15 20 15652477
   PubMed Web of Science ®Google Scholar
• Liu NK Xu XM MicroRNA in central nervous system trauma and degenerative disorders Physiol Genomics 2011 43 10 571 580 21385946
   PubMed Web of Science ®Google Scholar
• Fortin DL Troyer MD Nakamura K Kubo S Anthony MD Edwards RH Lipid rafts mediate the synaptic localization of alpha-synuclein J Neurosci 2004 24 30 6715 6723 15282274
   PubMed Web of Science ®Google Scholar
• Spillantini MG Goedert M The alpha-synucleinopathies: Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy Ann N Y Acad Sci 2000 920 16 27 11193145
   PubMed Web of Science ®Google Scholar
• Spillantini MG Schmidt ML Lee VM Trojanowski JQ Jakes R Goedert M Alpha-synuclein in lewy bodies Nature 1997 388 6645 839 840 9278044
   PubMed Web of Science ®Google Scholar
• Conway KA Lee SJ Rochet JC Ding TT Williamson RE Lansbury PT Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson’s disease: implications for pathogenesis and therapy Proc Natl Acad Sci U S A 2000 97 2 571 576 10639120
   PubMed Web of Science ®Google Scholar
• Eriksen JL Dawson TM Dickson DW Petrucelli L Caught in the act: alpha-synuclein is the culprit in Parkinson’s Disease Neuron 2003 40 3 453 456 14642269
   PubMed Web of Science ®Google Scholar
• Mutez E SNCA locus duplication carriers: from genetics to Parkinson disease phenotypes Hum Mutat 2011 32 4 E2079 E2090 21412942
   PubMed Web of Science ®Google Scholar
• Sekine T Clinical course of the first Asian family with Parkinsonism related to SNCA triplication Mov Disord 2010 25 16 2871 2875 20818659
   PubMed Web of Science ®Google Scholar
• Cullen V Acid beta-glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter alpha-synuclein processing Ann Neurol 2011 69 6 940 953 21472771
   PubMed Web of Science ®Google Scholar
• Yavich L Tanila H Vepsalainen S Jäkälä P Role of alpha-synuclein in presynaptic dopamine recruitment J Neurosci 2004 24 49 11165 11170 15590933
   PubMed Web of Science ®Google Scholar
• Junn E Lee KW Jeong BS Chan TW Im JY Mouradian MM Repression of alpha-synuclein expression and toxicity by microRNA-7 Proc Natl Acad Sci U S A 2009 106 31 13052 13057 19628698
   PubMed Web of Science ®Google Scholar
• Doxakis E Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153 J Biol Chem 2010 285 17 12726 12734 20106983
   PubMed Web of Science ®Google Scholar
• Chen H Shalom-Feuerstein R Riley J miR-7 and miR-214 are specifically expressed during neuroblastoma differentiation, cortical development and embryonic stem cells differentiation, and control neurite outgrowth in vitro Biochem Biophys Res Commun 2010 394 4 921 927 20230785
   PubMed Web of Science ®Google Scholar
• Petrucelli L O’Farrell C Lockhart PJ Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons Neuron 2002 36 6 1007 1019 12495618
   PubMed Web of Science ®Google Scholar
• Stefanis L Larsen KE Rideout HJ Sulzer D Greene LA Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death J Neurosci 2001 21 24 9549 9560 11739566
   PubMed Web of Science ®Google Scholar
• Jiang H Wu YC Nakamura M Parkinson’s disease genetic mutations increase cell susceptibility to stress: mutant alpha-synuclein enhances H2O2- and Sin-1-induced cell death Neurobiol Aging 2007 28 11 1709 1717 16978743
   PubMed Web of Science ®Google Scholar
• Junn E Mouradian MM Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine Neurosci Lett 2002 320 3 146 150 11852183
   PubMed Web of Science ®Google Scholar
• Cheng AM Byrom MW Shelton J Ford LP Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis Nucleic Acids Res 2005 33 4 1290 1297 15741182
   PubMed Web of Science ®Google Scholar
• Lau P de Strooper B Dysregulated microRNAs in neurodegenerative disorders Semin Cell Dev Biol 2010 21 7 768 773 20080199
   PubMed Web of Science ®Google Scholar
• Farh KK Grimson A Jan C The widespread impact of mammalian MicroRNAs on mRNA repression and evolution Science 2005 310 5755 1817 1821 16308420
   PubMed Web of Science ®Google Scholar
• Behm-Ansmant I Rehwinkel J Doerks T Stark A Bork P Izaurralde E mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes Genes Dev 2006 20 14 1885 1898 16815998
   PubMed Web of Science ®Google Scholar
• Eulalio A Huntzinger E Nishihara T Rehwinkel J Fauser M Izaurralde E Deadenylation is a widespread effect of miRNA regulation RNA 2009 15 1 21 32 19029310
   PubMed Web of Science ®Google Scholar
• Paisan-Ruiz C Jain S Evans EW Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease Neuron 2004 44 4 595 600 15541308
   PubMed Web of Science ®Google Scholar
• Zimprich A Biskup S Leitner P Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology Neuron 2004 44 4 601 607 15541309
   PubMed Web of Science ®Google Scholar
• Gehrke S Imai Y Sokol N Lu B Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression Nature 2010 466 7306 637 641 20671708
   PubMed Web of Science ®Google Scholar
• Girling R Partridge JF Bandara LR A new component of the transcription factor DRTF1/E2F Nature 1993 362 6415 83 87 8446173
   PubMed Web of Science ®Google Scholar
• Ingram L Munro S Coutts A La Thangue N E2F-1 regulation by an unusual DNA damage-responsive DP partner subunit Cell Death Differ 2011 18 1 122 132 20559320
   PubMed Web of Science ®Google Scholar
• Zhao C Sun G Li S MicroRNA let-7b regulates neural stem cell proliferation and differentiation by targeting nuclear receptor TLX signaling Proc Natl Acad Sci U S A 2010 107 5 1876 1881 20133835
   PubMed Web of Science ®Google Scholar
• Cookson MR Parkinsonism due to mutations in PINK1, parkin, and DJ-1 and oxidative stress and mitochondrial pathways Cold Spring Harb Perspect Med 2012 2 9 a009415 22951446
   PubMed Web of Science ®Google Scholar
• Shimura H Hattori N Kubo S Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase Nat Genet 2000 25 3 302 305 10888878
   PubMed Web of Science ®Google Scholar
• Illarioshkin SN Periquet M Rawal N Mutation analysis of the parkin gene in Russian families with autosomal recessive juvenile parkinsonism Mov Disord 2003 18 8 914 919 12889082
   PubMed Web of Science ®Google Scholar
• Bonifati V Rizzu P van Baren MJ Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism Science 2003 299 5604 256 259 12446870
   PubMed Web of Science ®Google Scholar
• Ariga H Takahashi-Niki K Kato I Maita H Niki T Iguchi-Ariga SM Neuroprotective Function of DJ-1 in Parkinson’s Disease Oxid Med Cell Longev 2013 2013 683920 23766857
   PubMed Web of Science ®Google Scholar
• Shendelman S Jonason A Martinat C Leete T Abeliovich A DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation PLoS Biol 2004 2 11 e362 15502874
   PubMed Web of Science ®Google Scholar
• Demasi M Davies KJ Proteasome inhibitors induce intracellular protein aggregation and cell death by an oxygen-dependent mechanism FEBS Lett 2003 542 1–3 89 94 12729904
   PubMed Web of Science ®Google Scholar
• Dauer W Przedborski S Parkinson’s disease: Mechanisms and models Neuron 2003 39 6 889 909 12971891
   PubMed Web of Science ®Google Scholar
• Billia F Hauck L Grothe D Parkinson-susceptibility gene DJ-1/PARK7 protects the murine heart from oxidative damage in vivo Proc Natl Acad Sci U S A 2013 110 15 6085 6090 23530187
   PubMed Web of Science ®Google Scholar
• Irrcher I Aleyasin H Seifert EL Loss of the Parkinson’s disease-linked gene DJ-1 perturbs mitochondrial dynamics Hum Mol Genet 2010 19 19 3734 3746 20639397
   PubMed Web of Science ®Google Scholar
• Krebiehl G Ruckerbauer S Burbulla LF Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson’s disease-associated protein DJ-1 PLoS One 2010 5 2 e9367 20186336
   PubMed Web of Science ®Google Scholar
• Thomas KJ McCoy MK Blackinton J DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy Hum Mol Genet 2011 20 1 40 50 20940149
   PubMed Web of Science ®Google Scholar
• Wang X Petrie TG Liu Y Liu J Fujioka H Zhu X Parkinson’s disease-associated DJ-1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction J Neurochem 2012 121 5 830 839 22428580
   PubMed Web of Science ®Google Scholar
• Mandemakers W Morais VA De Strooper B A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases J Cell Sci 2007 120 Pt 10 1707 1716 17502481
   PubMed Web of Science ®Google Scholar
• Miñones-Moyano E Porta S Escaramís G MicroRNA profiling of Parkinson’s disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function Hum Mol Genet 2011 20 15 3067 3078 21558425
   PubMed Web of Science ®Google Scholar
• Shapshak P Molecule of the month: miRNA and Parkinson’s disease protein PARK2 Bioinformation 2013 9 8 381 382 23750085
   PubMedGoogle Scholar
• Saito Y Saito H MicroRNAs in cancers and neurodegenerative disorders Front Genet 2012 3 194 23056009
   PubMedGoogle Scholar
• Kim J Inoue K Ishii J A microRNA feedback circuit in midbrain dopamine neurons Science 2007 317 5842 1220 1224 17761882
   PubMed Web of Science ®Google Scholar
• Hebert SS De Strooper B Alterations of the microRNA network cause neurodegenerative disease Trends Neurosci 2009 32 4 199 206 19268374
   PubMed Web of Science ®Google Scholar
• Van den Munckhof P Luk KC Ste-Marie L Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons Development 2003 130 11 2535 2542 12702666
   PubMed Web of Science ®Google Scholar
• Hwang DY Ardayfo P Kang UJ Semina EV Kim KS Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice Brain Res Mol Brain Res 2003 114 2 123 131 12829322
   PubMedGoogle Scholar
• Martinat C Bacci JJ Leete T Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype Proc Natl Acad Sci U S A 2006 103 8 2874 2879 16477036
   PubMed Web of Science ®Google Scholar
• Nunes I Tovmasian LT Silva RM Burke RE Goff SP Pitx3 is required for development of substantia nigra dopaminergic neurons Proc Natl Acad Sci U S A 2003 100 7 4245 4250 12655058
   PubMed Web of Science ®Google Scholar
• Fuchs J Mueller JC Lichtner P The transcription factor PITX3 is associated with sporadic Parkinson’s disease Neurobiol Aging 2009 30 5 731 738 17905480
   PubMed Web of Science ®Google Scholar
• Bergman O Håkansson A Westberg L PITX3 polymorphism is associated with early onset Parkinson’s disease Neurobiol Aging 2010 31 1 114 117 18420308
   PubMed Web of Science ®Google Scholar
• Li J Dani JA Le WD The Role of Transcription Factor Pitx3 in Dopamine Neuron Development and Parkinson’s Disease Curr Top Med Chem 2009 9 10 855 859 19754401
   PubMed Web of Science ®Google Scholar
• Nelson PT Wang WX Rajeev BW MicroRNAs (miRNAs) in Neurodegenerative Diseases Brain Pathol 2008 18 1 130 138 18226108
   PubMed Web of Science ®Google Scholar
• Ohmachi S Watanabe Y Mikami T FGF-20, a novel neurotrophic factor, preferentially expressed in the substantia nigra pars compacta of rat brain Biochem Biophys Res Commun 2000 277 2 355 360 11032730
   PubMed Web of Science ®Google Scholar
• Ohmachi S Mikami T Konishi M Miyake A Itoh N Preferential neurotrophic activity of fibroblast growth factor-20 for dopaminergic neurons through fibroblast growth factor receptor-1c J Neurosci Res 2003 72 4 436 443 12704805
   PubMed Web of Science ®Google Scholar
• Sethupathy P Collins FS MicroRNA target site polymorphisms and human disease Trends Genet 2008 24 10 489 497 18778868
   PubMed Web of Science ®Google Scholar
• van der Walt JM Noureddine MA Kittappa R Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease Am J Hum Genet 2004 74 6 1121 1127 15122513
   PubMed Web of Science ®Google Scholar
• Wang WX Rajeev BW Stromberg AJ The expression of microRNA miR-107 decreases early in Alzheimer‘s disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1 J Neurosci 2008 28 5 1213 1223 18234899
   PubMed Web of Science ®Google Scholar
• Davis TH Cuellar TL Koch SM Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus J Neurosci 2008 28 17 4322 4330 18434510
   PubMed Web of Science ®Google Scholar
• Wang G van der Walt JM Mayhew G Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein Am J Hum Genet 2008 82 2 283 289 18252210
   PubMed Web of Science ®Google Scholar
• Wider C Dachsel JC Soto AI FGF20 and Parkinson‘s disease: no evidence of association or pathogenicity via alpha-synuclein expression Mov Disord 2009 24 3 455 459 19133659
   PubMed Web of Science ®Google Scholar
• de Mena L Cardo LF Coto E FGF20 rs12720208 SNP and microRNA-433 variation: no association with Parkinson’s disease in Spanish patients Neurosci Lett 2010 479 1 22 25 20471450
   PubMed Web of Science ®Google Scholar
• Bumcrot D Manoharan M Koteliansky V Sah DW RNAi therapeutics: a potential new class of pharmaceutical drugs Nat Chem Biol 2006 2 12 711 719 17108989
   PubMed Web of Science ®Google Scholar
• de Fougerolles A Vornlocher HP Maraganore J Lieberman J Interfering with disease: a progress report on siRNA-based therapeutics Nat Rev Drug Discov 2007 6 6 443 453 17541417
   PubMed Web of Science ®Google Scholar
• Lewis J Melrose H Bumcrot D In vivo silencing of alpha-synuclein using naked siRNA Mol Neurodegener 2008 3 19 18976489
   PubMed Web of Science ®Google Scholar
• Sapru MK Yates JW Hogan S Jiang L Halter J Bohn MC Silencing of human alpha-synuclein in vitro and in rat brain using lentiviral-mediated RNAi Exp Neurol 2006 198 2 382 390 16455076
   PubMed Web of Science ®Google Scholar
• Blow N Small RNAs: delivering the future Nature 2007 450 7172 1117 1120 18075597
   PubMed Web of Science ®Google Scholar
• Mack G MicroRNA gets down to business Nat Biotechnol 2007 25 6 631 638 17557095
   PubMed Web of Science ®Google Scholar
• McBride JL Boudreau RL Harper SQ Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi Proc Natl Acad Sci U S A 2008 105 15 5868 5873 18398004
   PubMed Web of Science ®Google Scholar
• Boudreau RL McBride JL Martins I Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington’s disease mice Mol Ther 2009 17 6 1053 1063 19240687
   PubMed Web of Science ®Google Scholar
• Junn E Mouradian MM MicroRNAs in neurodegenerative diseases and their therapeutic potential Pharmacol Ther 2012 133 2 142 150 22008259
   PubMed Web of Science ®Google Scholar
• Boissonneault V Plante I Rivest S Provost P MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1 J Biol Chem 2009 284 4 1971 1981 18986979
   PubMed Web of Science ®Google Scholar
• Hébert SS Horré K Nicolai L Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer’s disease correlates with increased BACE1/beta-secretase expression Proc Natl Acad Sci U S A 2008 105 17 6415 6420 18434550
   PubMed Web of Science ®Google Scholar
• Zhao X He X Han X MicroRNA-mediated control of oligodendrocyte differentiation Neuron 2010 65 5 612 626 20223198
   PubMed Web of Science ®Google Scholar
• Meister G Landthaler M Dorsett Y Tuschl T Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing RNA 2004 10 3 544 550 14970398
   PubMed Web of Science ®Google Scholar
• Krützfeldt J Rajewsky N Braich R Silencing of microRNAs in vivo with ‘antagomirs’ Nature 2005 438 7068 685 689 16258535
   PubMed Web of Science ®Google Scholar
• Elmén J Lindow M Schütz S LNA-mediated microRNA silencing in non-human primates Nature 2008 452 7189 896 899 18368051
   PubMed Web of Science ®Google Scholar
• Elmén J Lindow M Silahtaroglu A Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver Nucleic Acids Res 2008 36 4 1153 1162 18158304
   PubMed Web of Science ®Google Scholar
• Lanford RE Hildebrandt-Eriksen ES Petri A Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection Science 2010 327 5962 198 201 19965718
   PubMed Web of Science ®Google Scholar
• Li Y Kowdley KV MicroRNAs in common human diseases Genomics Proteomics Bioinformatics 2012 10 5 246 253 23200134
   PubMedGoogle Scholar
• Asikainen S Rudgalvyte M Heikkinen L Global microRNA expression profiling of Caenorhabditis elegans Parkinson’s disease models J Mol Neurosci 2010 41 1 210 218 20091141
   PubMed Web of Science ®Google Scholar